Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 12Neoplasms 7Breast Neoplasms 4Hypogonadism 3Eunuchism 3Testicular Neoplasms 2Polycystic Ovary Syndrome 2Obesity 2Metabolic Syndrome 2Fatigue 2Dyspareunia 2Vaginitis 1Sleep Apnea, Obstructive 1Sleep Apnea Syndromes 1Sexuality 1Sexual Dysfunction, Physiological 1Sarcopenia 1Non-alcoholic Fatty Liver Disease 1Neoplasm Metastasis 1Muscle Weakness 1Multiple Endocrine Neoplasia Type 1 1Motor Activity 1Metabolic Diseases 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma 1Infertility 1Hot Flashes 1Diabetes Mellitus 1Colorectal Neoplasms 1Cardiovascular Diseases 1

Interventions

Radiosurgery 79Capecitabine 77Oxaliplatin 74Fluorouracil 69Bevacizumab 69Gemcitabine 67Leucovorin 61pembrolizumab 53Nivolumab 53Paclitaxel 48Irinotecan 47Radiotherapy 45Cisplatin 44Everolimus 38Magnetic Resonance Spectroscopy 36Drug Therapy 36Docetaxel 36Cyclophosphamide 35Cetuximab 35Ipilimumab 32Carboplatin 32Trastuzumab 31Sunitinib 30Sorafenib 26Erlotinib Hydrochloride 25Doxorubicin 23Surveys and Questionnaires 20Surgical Procedures, Operative 20Specimen Handling 20Biopsy 19

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Neoplasm Metastasis × Testosterone × Clear all
NCT00853697 2015-10-30

Exogenous Testosterone Plus Dutasteride for the Treatment of Castrate Metastatic Prostate Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
6 enrolled
Genitourinary

Neoplasm Metastasis, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡